The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-center retrospective cohort study evaluating the role of neoadjuvant chemotherapy in malignant peritoneal mesothelioma.
 
Xiao Wang
No Relationships to Disclose
 
Sharyn I. Katz
Consulting or Advisory Role - Trizell
Research Funding - Novartis
 
Leonid Roshkovan
No Relationships to Disclose
 
Suzanne Walker
No Relationships to Disclose
 
Sally McNulty
No Relationships to Disclose
 
Christine Agnes Ciunci
Honoraria - Imedex; Imedex
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); MacroGenics (Inst); Merck (Inst)
 
John Muira
No Relationships to Disclose
 
Giorgos Karakousis
No Relationships to Disclose
 
Keith A. Cengel
Consulting or Advisory Role - Novocure
Patents, Royalties, Other Intellectual Property - US20190099491A1 Sensitizing Cells to Proton Radiation; US9999779B2 Cell, tissue and organ protection using a magnetic field
Travel, Accommodations, Expenses - Novocure
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Novocure; Pfizer; Takeda
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Lilly; Merck (Inst); Stem CentRx (Inst)
Other Relationship - Amgen; Lilly; Peregrine Pharmaceuticals; Synta
 
Melina Elpi Marmarelis
Stock and Other Ownership Interests - Bluebird Bio; Gilead Sciences; Johnson & Johnson; Merck; Pfizer; Portola Pharmaceuticals
Honoraria - Health Advances (I); Novocure; Targeted Oncology
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Lilly (Inst); Trizell (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Novocure
Other Relationship - Novartis